FDG-PET, PET/CT and conventional nuclear medicine procedures in the evaluation of lung cancer

D Hellwig, RP Baum, CM Kirsch - Nuklearmedizin …, 2009 - thieme-connect.com
… on the evaluation and treatment of lung cancer are … lung cancer will be the evaluation of
indeterminate lung lesions and the mediastinal and extrathoracic staging using FDG-PET or PET

PET evaluation of lung cancer

T Bunyaviroch, RE Coleman - Journal of nuclear medicine, 2006 - Soc Nuclear Med
… The development of 18 F-FDG PET has taken the evaluation of solitary pulmonary nodules
beyond morphologic and predictive analyses to functional and metabolic analyses of disease…

Lymph node staging in non-small cell lung cancer: evaluation by [18F] FDG positron emission tomography (PET).

A Guhlmann, M Storck, J Kotzerke, F Moog… - Thorax, 1997 - thorax.bmj.com
… vasive method for evaluating regional lymph nodes in patients with NSCLC.… for the
preoperative assessment of mediastinal or chest wall invasion of lung cancer,3 4 FDGPET imaging …

18F-FDG PET/CT in restaging and evaluation of response to therapy in lung cancer: state of the art

A Castello, S Rossi, E Lopci - Current Radiopharmaceuticals, 2020 - ingentaconnect.com
… utility of 18F-FDG PET/CT in treatment response evaluation and the restaging of lung cancer.
… with conventional imaging techniques for the detection of lung cancer recurrence. In this …

Clinical utility of F-18 FDG PET-CT in the initial evaluation of lung cancer

PH Madsen, PC Holdgaard, JB Christensen… - European journal of …, 2016 - Springer
… potential uses of PET-CT in lung cancer management (like screening and follow-up) are not
covered in this article, which focuses on the use of PET-CT in initial lung cancer evaluation. …

Non–Small Cell Lung Cancer: Evaluation of Pleural Abnormalities on CT Scans with 18F FDG PET1

GJ Schaffler, G Wolf, H Schoellnast, R Groell, A Maier… - Radiology, 2004 - pubs.rsna.org
… The aim of this study was to evaluate the accuracy of 18 F FDG PET in the differentiation of
pleural malignancy and cancer-unrelated pleural disease in patients with NSCLC and pleural …

Chemotherapy response evaluation with 18F-FDG PET in patients with non-small cell lung cancer

LF de Geus-Oei, HFM van der Heijden… - Journal of nuclear …, 2007 - Soc Nuclear Med
… to evaluate the value of 18 F-FDG PET for the assessment of chemotherapy response in
patients with non–small cell lung cancer. … Methods: In 51 patients, dynamic 18 F-FDG PET was …

The value of FDG PET/CT in treatment response assessment, follow-up, and surveillance of lung cancer

S Sheikhbahaei, E Mena… - American Journal of …, 2017 - Am Roentgen Ray Soc
… role of FDG PET/CT in treatment response assessment and surveillance of lung cancer and
to … FDG PET/CT is a valuable imaging tool for assessing treatment response for patients with …

FDG PET/CT for evaluation of immunotherapy response in lung cancer patients

MA Léger, B Routy, D Juneau - Seminars in nuclear medicine, 2022 - Elsevier
… In this article, we will review the role FDG PET/CT can play in the assessment of response …
, review the anatomical and metabolical response criteria to systemic therapies in solid tumors

The use of positron emission tomography (PET) in the staging/evaluation, treatment, and follow-up of patients with lung cancer: a critical review

M Mac Manus, RJ Hicks - … Journal of Radiation Oncology* Biology* Physics, 2008 - Elsevier
… (PET) is increasing rapidly in the developed world (1). This article reviews the role of PET
scanning in lung cancer, … lesions with higher FDG uptake are more likely to be malignant. In a …